- £1.02bn
- £984.36m
- $1.19bn
- 43
- 63
- 41
- 44
Annual income statement for Indivior, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 647 | 791 | 901 | 1,093 | 1,188 |
Cost of Revenue | |||||
Gross Profit | 555 | 664 | 756 | 933 | 1,013 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 810 | 587 | 982 | 1,249 | 1,156 |
Operating Profit | -163 | 204 | -81 | -156 | 32 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -173 | 190 | -89 | -149 | 14 |
Provision for Income Taxes | |||||
Net Income After Taxes | -148 | 205 | -45 | -129 | 3 |
Net Income Before Extraordinary Items | |||||
Net Income | -148 | 205 | -45 | -129 | 3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -148 | 205 | -43 | -129 | 2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.955 | 1.6 | 1.1 | 1.52 | 1.31 |